LIN9 Antikörper (AA 441-540) (Cy5.5)
-
- Target Alle LIN9 Antikörper anzeigen
- LIN9 (Lin-9 Homolog (LIN9))
-
Bindungsspezifität
- AA 441-540
-
Reaktivität
- Human, Maus, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LIN9 Antikörper ist konjugiert mit Cy5.5
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Affe, Maus
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human LIN9
- Isotyp
- IgG
- Top Product
- Discover our top product LIN9 Primärantikörper
-
anti-Lin-9 Homolog (LIN9) (AA 1-558) antibody
LIN9 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 5-103) antibodyLIN9 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 132-160), (N-Term) antibodyLIN9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB36930 unconjugated
anti-Lin-9 Homolog (LIN9) (AA 1-558) antibodyLIN9 Reaktivität: Human IP Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 155-204) antibodyLIN9 Reaktivität: Human, Maus, Affe, Ratte, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd, Zebrafisch (Danio rerio), Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 51-100) antibodyLIN9 Reaktivität: Human, Maus, Affe, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 350-470) antibodyLIN9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (N-Term) antibodyLIN9 Reaktivität: Human, Maus, Ratte, Zebrafisch (Danio rerio), Xenopus laevis, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (N-Term) antibodyLIN9 Reaktivität: Human, Maus, Ratte, Xenopus laevis WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- LIN9 (Lin-9 Homolog (LIN9))
- Andere Bezeichnung
- LIN9 (LIN9 Produkte)
- Synonyme
- BARA antikoerper, BARPsv antikoerper, Lin-9 antikoerper, TGS antikoerper, TGS1 antikoerper, TGS2 antikoerper, 2700022J23Rik antikoerper, AA537062 antikoerper, AA545216 antikoerper, Bara antikoerper, si:dkey-206f10.4 antikoerper, wu:fb79c09 antikoerper, wu:fi32a10 antikoerper, zgc:153599 antikoerper, lin-9 DREAM MuvB core complex component L homeolog antikoerper, lin-9 DREAM MuvB core complex component antikoerper, lin-9 homolog (C. elegans) antikoerper, lin9.L antikoerper, LIN9 antikoerper, Lin9 antikoerper, lin9 antikoerper
- Hintergrund
-
Synonyms: TGS, BARA, TGS1, TGS2, Lin-9, BARPsv, Protein lin-9 homolog, HuLin-9, hLin-9, Beta subunit-associated regulator of apoptosis, TUDOR gene similar protein, Type I interferon receptor beta chain-associated protein, pRB-associated protein, LIN9
Background: Acts as a tumor suppressor. Inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. Plays a role in the expression of genes required for the G1/S transition.
- Gen-ID
- 286826
- UniProt
- Q5TKA1
- Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
-
